Skip to main content
Top
Published in: Acta Diabetologica 4/2013

01-08-2013 | Review Article

Preoperatively determinable factors predictive of diabetes mellitus remission following Roux-en-Y gastric bypass: a review of the literature

Authors: ST Adams, M. Salhab, ZI Hussain, GV Miller, SH Leveson

Published in: Acta Diabetologica | Issue 4/2013

Login to get access

Abstract

It is well established that weight loss in general and bariatric surgery in particular can improve glycaemic control in diabetics. Current NICE guidelines recommend that those patients with type 2 diabetes mellitus and a BMI of 35 kg/m2 or more should be considered for bariatric surgery in order to optimise their glycaemic control and minimise their risk of long-term complications. The commonest bariatric procedure in the UK is the Roux-en-Y gastric bypass that has been shown to result in long-standing type 2 diabetes resolution in 83 % of patients. Since such surgery carries a small but significant risk of mortality, as well as posing considerable lifestyle implications for the patient, numerous studies have been performed with a view to identifying which patients and which procedures are most likely to result in these desired benefits. This paper summarises the existing literature on this topic.
Literature
1.
go back to reference Buchwald H, Estok R, Fahrbach K et al (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122(248–256):e245 Buchwald H, Estok R, Fahrbach K et al (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122(248–256):e245
2.
go back to reference Fobi MA (2010) P-119 Is the effect of gastric bypass on type 2 diabetes permanent? 27th Annual Meeting of the ASMBS, Las Vegas, Nevada, US, p s67 Fobi MA (2010) P-119 Is the effect of gastric bypass on type 2 diabetes permanent? 27th Annual Meeting of the ASMBS, Las Vegas, Nevada, US, p s67
3.
go back to reference Meijer RI, van Wagensveld BA, Siegert CE, Eringa EC, Serne EH, Smulders YM (2011) Bariatric surgery as a novel treatment for type 2 diabetes mellitus: a systematic review. Arch Surg 146:744–750PubMedCrossRef Meijer RI, van Wagensveld BA, Siegert CE, Eringa EC, Serne EH, Smulders YM (2011) Bariatric surgery as a novel treatment for type 2 diabetes mellitus: a systematic review. Arch Surg 146:744–750PubMedCrossRef
4.
go back to reference Buse JB, Caprio S, Cefalu WT et al (2009) How do we define cure of diabetes? Diabetes Care 32:2133–2135PubMedCrossRef Buse JB, Caprio S, Cefalu WT et al (2009) How do we define cure of diabetes? Diabetes Care 32:2133–2135PubMedCrossRef
5.
go back to reference Burcelin R, Serino M, Chabo C, Blasco-Baque V, Amar J (2011) Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol 48:257–273PubMedCrossRef Burcelin R, Serino M, Chabo C, Blasco-Baque V, Amar J (2011) Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol 48:257–273PubMedCrossRef
6.
go back to reference Amar J, Serino M, Lange C et al (2011) Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia 54:3055–3061PubMedCrossRef Amar J, Serino M, Lange C et al (2011) Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia 54:3055–3061PubMedCrossRef
7.
go back to reference Ishida RK, Faintuch J, Paula AM et al (2007) Microbial flora of the stomach after gastric bypass for morbid obesity. Obes Surg 17:752–758PubMedCrossRef Ishida RK, Faintuch J, Paula AM et al (2007) Microbial flora of the stomach after gastric bypass for morbid obesity. Obes Surg 17:752–758PubMedCrossRef
8.
go back to reference Dixon JB, le Roux CW, Rubino F, Zimmet P (2012) Bariatric surgery for type 2 diabetes. Lancet 379:2300–2311PubMedCrossRef Dixon JB, le Roux CW, Rubino F, Zimmet P (2012) Bariatric surgery for type 2 diabetes. Lancet 379:2300–2311PubMedCrossRef
9.
go back to reference Pournaras DJ, Osborne A, Hawkins SC et al (2010) Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg 252:966–971PubMedCrossRef Pournaras DJ, Osborne A, Hawkins SC et al (2010) Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg 252:966–971PubMedCrossRef
10.
go back to reference Thaler JP, Cummings DE (2009) Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 150:2518–2525PubMedCrossRef Thaler JP, Cummings DE (2009) Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 150:2518–2525PubMedCrossRef
11.
go back to reference Vetter ML, Ritter S, Wadden TA, Sarwer DB (2012) Comparison of bariatric surgical procedures for diabetes remission: efficacy and mechanisms. Diabetes Spectr 25:200–210PubMedCrossRef Vetter ML, Ritter S, Wadden TA, Sarwer DB (2012) Comparison of bariatric surgical procedures for diabetes remission: efficacy and mechanisms. Diabetes Spectr 25:200–210PubMedCrossRef
12.
go back to reference Frachetti KJ, Goldfine AB (2009) Bariatric surgery for diabetes management. Curr Opin Endocrinol Diabetes Obes 16:119–124PubMedCrossRef Frachetti KJ, Goldfine AB (2009) Bariatric surgery for diabetes management. Curr Opin Endocrinol Diabetes Obes 16:119–124PubMedCrossRef
13.
go back to reference Herron DM, Tong W (2009) Role of surgery in management of type 2 diabetes mellitus. Mt Sinai J Med 76:281–293PubMedCrossRef Herron DM, Tong W (2009) Role of surgery in management of type 2 diabetes mellitus. Mt Sinai J Med 76:281–293PubMedCrossRef
14.
15.
go back to reference Tarquini R, Lazzeri C, Pala L, Rotella CM, Gensini GF (2010) The diabetic cardiomyopathy. Acta Diabetol 48:173–181PubMedCrossRef Tarquini R, Lazzeri C, Pala L, Rotella CM, Gensini GF (2010) The diabetic cardiomyopathy. Acta Diabetol 48:173–181PubMedCrossRef
16.
go back to reference Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321PubMedCrossRef Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321PubMedCrossRef
17.
go back to reference Pories WJ, Swanson MS, MacDonald KG et al (1995) Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339–350 Discussion 350–332PubMedCrossRef Pories WJ, Swanson MS, MacDonald KG et al (1995) Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339–350 Discussion 350–332PubMedCrossRef
18.
go back to reference Sjostrom L, Lindroos AK, Peltonen M et al (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693PubMedCrossRef Sjostrom L, Lindroos AK, Peltonen M et al (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693PubMedCrossRef
19.
go back to reference Pournaras D, Aasheim E, Sovik T, et al. (2011) A05: Remission of Type 2 diabetes mellitus after bariatric surgery according to the 2009 American Diabetes Association Criteria. 28th Annual Meeting of the American Society for Metabolic and Bariatric Surgery, Orlando, Florida, US, pp 247–248 Pournaras D, Aasheim E, Sovik T, et al. (2011) A05: Remission of Type 2 diabetes mellitus after bariatric surgery according to the 2009 American Diabetes Association Criteria. 28th Annual Meeting of the American Society for Metabolic and Bariatric Surgery, Orlando, Florida, US, pp 247–248
20.
go back to reference Gagne DJ, Gill G, Urbandt J (2010) P-118: Improvement in Type 1 diabetes after laparoscopic Roux-en-Y gastric bypass. 27th Annual Meeting of the American Society for Metabolic and Bariatric Surgery, Las Vegas, Nevada, US, p S66 Gagne DJ, Gill G, Urbandt J (2010) P-118: Improvement in Type 1 diabetes after laparoscopic Roux-en-Y gastric bypass. 27th Annual Meeting of the American Society for Metabolic and Bariatric Surgery, Las Vegas, Nevada, US, p S66
21.
go back to reference Lee WJ, Chong K, Ser KH et al (2011) Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 146:143–148PubMedCrossRef Lee WJ, Chong K, Ser KH et al (2011) Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 146:143–148PubMedCrossRef
22.
go back to reference Boza C, Munoz R, Salinas J et al (2011) Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients. Obes Surg 21:1330–1336PubMedCrossRef Boza C, Munoz R, Salinas J et al (2011) Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients. Obes Surg 21:1330–1336PubMedCrossRef
23.
go back to reference Reis CE, Alvarez-Leite JI, Bressan J, Alfenas RC (2012) Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m(2): a literature review. Diabetes Technol Ther 14(4):365–372 Reis CE, Alvarez-Leite JI, Bressan J, Alfenas RC (2012) Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m(2): a literature review. Diabetes Technol Ther 14(4):365–372
24.
go back to reference Hayes MT, Hunt LA, Foo J, Tychinskaya Y, Stubbs RS (2011) A model for predicting the resolution of type 2 diabetes in severely obese subjects following Roux-en Y gastric bypass surgery. Obes Surg 21:910–916PubMedCrossRef Hayes MT, Hunt LA, Foo J, Tychinskaya Y, Stubbs RS (2011) A model for predicting the resolution of type 2 diabetes in severely obese subjects following Roux-en Y gastric bypass surgery. Obes Surg 21:910–916PubMedCrossRef
25.
go back to reference Hamza N, Abbas MH, Darwish A, Shafeek Z, New J, Ammori BJ (2011) Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis 7:691–696PubMedCrossRef Hamza N, Abbas MH, Darwish A, Shafeek Z, New J, Ammori BJ (2011) Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis 7:691–696PubMedCrossRef
26.
go back to reference Kadera BE, Lum K, Grant J, Pryor AD, Portenier DD, Demaria EJ (2009) Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss. Surg Obes Relat Dis 5:305–309PubMedCrossRef Kadera BE, Lum K, Grant J, Pryor AD, Portenier DD, Demaria EJ (2009) Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss. Surg Obes Relat Dis 5:305–309PubMedCrossRef
27.
go back to reference Lee WJ, Lee YC, Chen JC, Ser KH, Su YH, Chen SC (2010) Preoperative Predictors of Type 2 diabetes resolution after bariatric surgery 27th Annual meeting of the American society for metabolic and bariatric surgery. Surgery for obesity and related diseases. Las Vegas, Nevada, p S23 Lee WJ, Lee YC, Chen JC, Ser KH, Su YH, Chen SC (2010) Preoperative Predictors of Type 2 diabetes resolution after bariatric surgery 27th Annual meeting of the American society for metabolic and bariatric surgery. Surgery for obesity and related diseases. Las Vegas, Nevada, p S23
28.
go back to reference Hall TC, Pellen MG, Sedman PC, Jain PK (2010) Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg 20:1245–1250PubMedCrossRef Hall TC, Pellen MG, Sedman PC, Jain PK (2010) Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg 20:1245–1250PubMedCrossRef
29.
go back to reference Maciejewski ML, Livingston EH, Kahwati LC, Henderson WG, Kavee AL, Arterburn DE (2010) Discontinuation of diabetes and lipid-lowering medications after bariatric surgery at veterans affairs medical centers. Surg Obes Relat Dis 6:601–607PubMedCrossRef Maciejewski ML, Livingston EH, Kahwati LC, Henderson WG, Kavee AL, Arterburn DE (2010) Discontinuation of diabetes and lipid-lowering medications after bariatric surgery at veterans affairs medical centers. Surg Obes Relat Dis 6:601–607PubMedCrossRef
30.
go back to reference Zeni T, Kapur S, Lark TR, Magid P (2009) Diabetes mellitus and insulin resolution after laparoscopic Roux-en-Y gastric bypass. 26th Annual Meeting of the American Society for Metabolic and Bariatric Surgery, Grapevine, Texas, USA, p S43 Zeni T, Kapur S, Lark TR, Magid P (2009) Diabetes mellitus and insulin resolution after laparoscopic Roux-en-Y gastric bypass. 26th Annual Meeting of the American Society for Metabolic and Bariatric Surgery, Grapevine, Texas, USA, p S43
31.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef
32.
go back to reference Perugini RA, Shah SA, Kelly JJ, Czerniach DR, Litwin DE, Gallagher-Dorval KA (2009) HOMA estimated glucose disposition index predicts resolution of type 2 diabetes mellitus following laparoscopic gastric bypass 26th Annual Meeting of the American Society for Metabolic and Bariatric Surgery. Surgery for Obesity and Related Diseases, Grapevine, Texas, USA, p S1 Perugini RA, Shah SA, Kelly JJ, Czerniach DR, Litwin DE, Gallagher-Dorval KA (2009) HOMA estimated glucose disposition index predicts resolution of type 2 diabetes mellitus following laparoscopic gastric bypass 26th Annual Meeting of the American Society for Metabolic and Bariatric Surgery. Surgery for Obesity and Related Diseases, Grapevine, Texas, USA, p S1
33.
go back to reference Chikunguwo SM, Wolfe LG, Dodson P et al (2010) Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis 6:254–259PubMedCrossRef Chikunguwo SM, Wolfe LG, Dodson P et al (2010) Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis 6:254–259PubMedCrossRef
34.
go back to reference DiGiorgi M, Rosen DJ, Choi JJ et al (2010) Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis 6:249–253PubMedCrossRef DiGiorgi M, Rosen DJ, Choi JJ et al (2010) Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis 6:249–253PubMedCrossRef
35.
go back to reference Deitel M (2009) Slow-progression, autoimmune, type 1 diabetes in adults: a cause of failure of resolution of diabetes after bariatric surgery. Surg Obes Relat Dis 5:705–706PubMedCrossRef Deitel M (2009) Slow-progression, autoimmune, type 1 diabetes in adults: a cause of failure of resolution of diabetes after bariatric surgery. Surg Obes Relat Dis 5:705–706PubMedCrossRef
36.
go back to reference Stenstrom G, Gottsater A, Bakhtadze E, Berger B, Sundkvist G (2005) Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment. Diabetes 54(Suppl 2):S68–S72PubMedCrossRef Stenstrom G, Gottsater A, Bakhtadze E, Berger B, Sundkvist G (2005) Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment. Diabetes 54(Suppl 2):S68–S72PubMedCrossRef
Metadata
Title
Preoperatively determinable factors predictive of diabetes mellitus remission following Roux-en-Y gastric bypass: a review of the literature
Authors
ST Adams
M. Salhab
ZI Hussain
GV Miller
SH Leveson
Publication date
01-08-2013
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 4/2013
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-013-0453-2

Other articles of this Issue 4/2013

Acta Diabetologica 4/2013 Go to the issue